FDA Approved: KETOCONAZOLE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental ANDA for Ketoconazole, a generic antifungal product from E. Fougera & Co. (division of Fougera Pharmaceuticals).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Candidiasis
• Dermatophytosis
• Seborrheic Dermatitis
• Tinea Corporis
• Tinea Cruris
• Tinea Versicolor

Drugs mentioned

• Ketoconazole (Ketoconazole)

Snippet

SUPPL AP for KETOCONAZOLE (KETOCONAZOLE)